Magvit B6 (Magnesium, Pyridoxine Hydrochloride)

Magnesium serves as a co‑factor for hundreds of enzymatic reactions, including those that generate cellular energy and regulate ion channels. Pyridoxine hydrochloride is converted to pyridoxal‑5′‑phosphate, a co‑enzyme essential for amino‑acid metabolism and neurotransmitter synthesis. Together they facilitate nerve impulse transmission, muscle contraction and metabolic processes.

The appropriate dose of Magvit B6 is determined by a qualified health‑care professional based on the individual’s age, clinical condition, laboratory results and any concurrent medications. Patients should follow the prescriber’s instructions and not exceed the recommended amount without medical advice.

Magvit B6 may be used in pregnancy or while breastfeeding only if the prescriber judges that the potential benefit outweighs any possible risk to the fetus or infant. Limited clinical data are available, so health‑care providers typically recommend the lowest effective dose and close monitoring.

To order Magvit B6, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Magvit B6 combines both magnesium and pyridoxine in a single oral formulation, which can simplify dosing compared with taking separate products. The combined preparation ensures coordinated delivery of the two cofactors that often act synergistically in nerve and muscle metabolism, whereas single‑ingredient supplements address only one of the nutritional gaps.

Store Magvit B6 at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight and extreme heat. Ensure the container is tightly closed after each use to maintain potency and prevent contamination.

Magvit B6 is taken orally, usually with water. The tablet or capsule should be swallowed whole and can be taken with or without food, unless the prescribing clinician advises otherwise. Patients should not crush or chew the dosage form, as this may affect absorption.

The most serious risks include hypermagnesemia, which can cause muscle weakness, low blood pressure, cardiac arrhythmias, and severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. Anyone experiencing difficulty breathing, swelling of the face or throat, or unexplained cardiac symptoms should seek immediate medical attention.

Magvit B6 should be avoided by individuals with known hypersensitivity to magnesium, pyridoxine or any excipients in the product, and by patients with existing hypermagnesemia. Those with severe renal impairment should also refrain from use unless a health‑care professional explicitly advises otherwise.